Source: FinanzNachrichten

Visterra: Scailyte and Visterra Partner to Advance Autoimmune Disease Research

BASEL, SWITZERLAND and WALTHAM, MA / ACCESSWIRE / December 16, 2024 / Scailyte AG, an AI-driven biomarker discovery company, and Visterra, Inc., a clinical-stage biopharmaceutical company, today an...

Read full article »
Visterra's Competitors | Visterra's News | Visterra's Financials
Stay up-to-date with the latest news on Visterra
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Brian J. G. Pereira's photo - President & CEO of Visterra

President & CEO

Brian J. G. Pereira

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Visterra